Mitochondrial myopathy

Dec 20, 2019

Stealth BioTherapeutics Provides Update on Phase 3 Trial of Elamipretide in Primary Mitochondrial Myopathy

Oct 17, 2019

Stealth BioTherapeutics Presents Data for Elamipretide on Cardiac Function in Barth Syndrome

Sep 03, 2019

Stealth BioTherapeutics Announces Appointment of Robert Weiskopf as Chief Financial Officer

Apr 25, 2019

Stealth BioTherapeutics Completes Enrollment of Pivotal Study in Primary Mitochondrial Myopathy

Apr 02, 2019

Stealth BioTherapeutics to Present at H.C. Wainwright Global Life Sciences Conference

Apr 20, 2018

NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference

Jan 29, 2018

NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project

Nov 30, 2017

NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone